Please provide your email address to receive an email when new articles are posted on . The reductions after treatment with evinacumab (Evkeeza, Regeneron) were evident in certain patients from two ...

Please provide your email address to receive an email when new articles are posted on . While rare, certain genetic and multifactorial causes of severe hypertriglyceridemia may warrant special ...

ATLANTA -- A novel antisense mRNA drug slashed triglycerides in higher risk or moderate hypertriglyceridemia patients and in those with extremely elevated levels from familial chylomicronemia syndrome ...

Credit: Getty Images. Olezarsen is an investigational LICA antisense medication designed to inhibit the production of apoC-III for patients at risk of disease due to elevated triglyceride levels. The ...

Evinacumab (Evkeeza; Regeneron) can substantially reduce fasting triglyceride levels in patients with severe hypertriglyceridemia, although to a variable degree and not among those with the rare ...

Mammoth Biosciences Inc. has nominated its first clinical development candidate – MB-111 – a potential one-time treatment for patients with very high triglycerides, including familial chylomicronemia ...

In this study, familial chylomicronemia syndrome was associated with small nerve fiber damage, neuropathic symptoms, cardiac autonomic dysfunction, and elevated vibration perception. What does this ...